[Effect of human epidermal factor (hEGF) on antitumor activity of 5-fluorouracil (5-FU) in human gastric cancer cell lines].
Saito
D
D
Dept. of Internal Medicine, National Cancer Center Hospital.
Yoshida
S
S
Okazaki
N
N
Ohkura
H
H
D000230:Adenocarcinoma / Q000032:analysis / Q000473:pathology; D002288:Adenocarcinoma, Mucinous / Q000032:analysis / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D066246:ErbB Receptors / Q000032:analysis; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D013274:Stomach Neoplasms / Q000032:analysis / Q000473:pathology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D005472:Fluorouracil